Accuray and limbus ai unveil online adaptive therapy solution for the radixact® system at american society for radiation oncology (astro) annual meeting

Madison, wis. , oct. 2, 2023 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today that the company has a 510(k) pending for an online adaptive therapy option*, cenos™, for its radixact ® system.

ARAY Ratings Summary

ARAY Quant Ranking